Genetic Analysis of Extramammary Paget's Disease
Author Information
Author(s): M Takata, N Hatta, K Takehara
Primary Institution: Kanazawa University School of Medicine
Hypothesis
What are the genetic defects underlying the pathogenesis of extramammary Paget's disease?
Conclusion
The study found no p53 mutations or allelic loss at several loci commonly implicated in other cancers, suggesting different underlying genetic defects in extramammary Paget's disease.
Supporting Evidence
- No LOH was detected at several loci commonly lost in other human cancers.
- Altered p53 protein expression was entirely or mostly negative in all cases.
- Direct sequencing of the p53 gene revealed no mutations in the examined cases.
- HPV DNA was not detected in any of the tumours.
- Overexpression of c-erbB-2 protein was observed in 6 out of 14 tumours.
Takeaway
This study looked at a type of skin cancer called extramammary Paget's disease and found that it doesn't have the same genetic problems as other cancers.
Methodology
The study examined loss of heterozygosity (LOH), p53 and HPV status, and the expression of c-erbB-2 and bcl-2 proteins in 14 cases of extramammary Paget's disease.
Potential Biases
Potential selection bias due to the case selection process.
Limitations
The study did not examine chromosome regions that may also be important in the pathogenesis of extramammary Paget's disease.
Participant Demographics
12 men and 2 women, with lesions typical of extramammary Paget's disease on genital skin and vulvar or pubic lesions.
Want to read the original?
Access the complete publication on the publisher's website